Combat Drugs to divest Singapore subsidiary

05 Nov 2019 Evaluate

Combat Drugs has received an approval for the full Disinvestment of the Fully Owned Subsidiary of the company in Singapore i.e. RA Labs by sale of entire Equity Shares held by the company, at cost, subject to shareholder approval and other statutory approvals, as applicable, if any. The Board of Directors of the company in their meeting approved the same.

Combat Drugs manufactures and markets pharmaceutical formulations in India. The company offers its products in various forms, such as tablets, capsules, liquid orals, and ointments.

Decipher Labs Share Price

12.00 -0.18 (-1.48%)
25-Apr-2025 13:34 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1791.45
Dr. Reddys Lab 1174.55
Cipla 1533.10
Lupin 2047.85
Zydus Lifesciences 866.15
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
×
Please wait your portfolio is updating...